Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04052880
Title Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ajai Chari

multiple myeloma


Daratumumab + Ixazomib

Bortezomib + Daratumumab + Dexamethasone + Lenalidomide

Daratumumab + Lenalidomide

Age Groups: senior
Covered Countries USA

No variant requirements are available.